158 related articles for article (PubMed ID: 35090304)
1. Design of a Novel Recombinant Multi-Epitope Vaccine against Triple-Negative Breast Cancer.
Dariushnejad H; Ghorbanzadeh V; Akbari S; Hashemzadeh P
Iran Biomed J; 2022 Mar; 26(2):160-74. PubMed ID: 35090304
[TBL] [Abstract][Full Text] [Related]
2. Structural immunoinformatics approach for rational design of a multi-epitope vaccine against triple negative breast cancer.
T D; Kamaraj B; Vasudevan K; Gopikrishnan M; K R D; Rambabu M; C GPD
Int J Biol Macromol; 2023 Jul; 243():125209. PubMed ID: 37271264
[TBL] [Abstract][Full Text] [Related]
3. Designing a novel SOX9 based multi-epitope vaccine to combat metastatic triple-negative breast cancer using immunoinformatics approach.
Rajendran Krishnamoorthy H; Karuppasamy R
Mol Divers; 2023 Aug; 27(4):1829-1842. PubMed ID: 36214961
[TBL] [Abstract][Full Text] [Related]
4. Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach.
Paranthaman P; Veerappapillai S
Med Oncol; 2023 Feb; 40(3):105. PubMed ID: 36823384
[TBL] [Abstract][Full Text] [Related]
5. A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches.
Negahdaripour M; Eslami M; Nezafat N; Hajighahramani N; Ghoshoon MB; Shoolian E; Dehshahri A; Erfani N; Morowvat MH; Ghasemi Y
Infect Genet Evol; 2017 Oct; 54():402-416. PubMed ID: 28780192
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics-Based Designing of a Multi-Epitope Chimeric Vaccine From Multi-Domain Outer Surface Antigens of
Kumar P; Lata S; Shankar UN; Akif M
Front Immunol; 2021; 12():735373. PubMed ID: 34917072
[TBL] [Abstract][Full Text] [Related]
7. Advancements and hurdles in the development of a vaccine for triple-negative breast cancer: A comprehensive review of multi-omics and immunomics strategies.
Dhanushkumar T; M E S; Selvam PK; Rambabu M; Dasegowda KR; Vasudevan K; George Priya Doss C
Life Sci; 2024 Jan; 337():122360. PubMed ID: 38135117
[TBL] [Abstract][Full Text] [Related]
8. Biotinylated Streptavidin Surface Coating Improves the Efficacy of a PLGA Microparticle-Based Cancer Vaccine.
Gross BP; Chitphet K; Wongrakpanich A; Wafa EI; Norian LA; Salem AK
Bioconjug Chem; 2020 Sep; 31(9):2147-2157. PubMed ID: 32786363
[TBL] [Abstract][Full Text] [Related]
9. A candidate triple-negative breast cancer vaccine design by targeting clinically relevant cell surface markers: an integrated immuno and bio-informatics approach.
Kumar S; Shuaib M; Prajapati KS; Singh AK; Choudhary P; Singh S; Gupta S
3 Biotech; 2022 Mar; 12(3):72. PubMed ID: 35223358
[TBL] [Abstract][Full Text] [Related]
10. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches.
Nezafat N; Karimi Z; Eslami M; Mohkam M; Zandian S; Ghasemi Y
Comput Biol Chem; 2016 Jun; 62():82-95. PubMed ID: 27107181
[TBL] [Abstract][Full Text] [Related]
11. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
Chand Y; Singh S
Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
[TBL] [Abstract][Full Text] [Related]
12. Design and In Silico Validation of a Novel MZF-1-Based Multi-Epitope Vaccine to Combat Metastatic Triple Negative Breast Cancer.
Krishnamoorthy HR; Karuppasamy R
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992161
[TBL] [Abstract][Full Text] [Related]
13. Designing a therapeutic and prophylactic candidate vaccine against human papillomavirus through vaccinomics approaches.
Bagheri A; Nezafat N; Eslami M; Ghasemi Y; Negahdaripour M
Infect Genet Evol; 2021 Nov; 95():105084. PubMed ID: 34547435
[TBL] [Abstract][Full Text] [Related]
14. Designing a multi-epitope vaccine for cross-protection against Shigella spp: An immunoinformatics and structural vaccinology study.
Nosrati M; Hajizade A; Nazarian S; Amani J; Namvar Vansofla A; Tarverdizadeh Y
Mol Immunol; 2019 Dec; 116():106-116. PubMed ID: 31634814
[TBL] [Abstract][Full Text] [Related]
15.
Parvizpour S; Razmara J; Pourseif MM; Omidi Y
Bioimpacts; 2019; 9(1):45-56. PubMed ID: 30788259
[No Abstract] [Full Text] [Related]
16. Immuno-informatics analysis and expression of a novel multi-domain antigen as a vaccine candidate against glioblastoma.
Gharbavi M; Danafar H; Amani J; Sharafi A
Int Immunopharmacol; 2021 Feb; 91():107265. PubMed ID: 33360829
[TBL] [Abstract][Full Text] [Related]
17. B19-VLPs as an effective delivery system for tumour antigens to induce humoral and cellular immune responses against triple negative breast cancer.
Jiménez-Chávez ÁJ; Nava-García BK; Bustos-Jaimes I; Moreno-Fierros L
Immunol Lett; 2021 Nov; 239():77-87. PubMed ID: 34508790
[TBL] [Abstract][Full Text] [Related]
18. Immunoinformatics analysis and in silico designing of a novel multi-epitope peptide vaccine against Staphylococcus aureus.
Hajighahramani N; Nezafat N; Eslami M; Negahdaripour M; Rahmatabadi SS; Ghasemi Y
Infect Genet Evol; 2017 Mar; 48():83-94. PubMed ID: 27989662
[TBL] [Abstract][Full Text] [Related]
19. Design of a Multi-Epitopes Vaccine against Hantaviruses: An Immunoinformatics and Molecular Modelling Approach.
Ismail S; Abbasi SW; Yousaf M; Ahmad S; Muhammad K; Waheed Y
Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35335010
[TBL] [Abstract][Full Text] [Related]
20. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
